"Cholesterol, HDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol.
| Descriptor ID |
D008076
|
| MeSH Number(s) |
D04.210.500.247.808.197.238 D10.532.432.400 D10.570.938.208.270 D12.776.521.479.470
|
| Concept/Terms |
Cholesterol, HDL- Cholesterol, HDL
- alpha-Lipoprotein Cholesterol
- Cholesterol, alpha-Lipoprotein
- alpha Lipoprotein Cholesterol
- HDL Cholesterol
- High Density Lipoprotein Cholesterol
|
Below are MeSH descriptors whose meaning is more general than "Cholesterol, HDL".
Below are MeSH descriptors whose meaning is more specific than "Cholesterol, HDL".
This graph shows the total number of publications written about "Cholesterol, HDL" by people in this website by year, and whether "Cholesterol, HDL" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 2 | 4 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 4 | 4 |
| 2001 | 4 | 8 | 12 |
| 2002 | 2 | 3 | 5 |
| 2003 | 3 | 12 | 15 |
| 2004 | 1 | 5 | 6 |
| 2005 | 4 | 8 | 12 |
| 2006 | 5 | 6 | 11 |
| 2007 | 3 | 4 | 7 |
| 2008 | 6 | 4 | 10 |
| 2009 | 3 | 5 | 8 |
| 2010 | 1 | 8 | 9 |
| 2011 | 7 | 14 | 21 |
| 2012 | 8 | 18 | 26 |
| 2013 | 7 | 9 | 16 |
| 2014 | 7 | 10 | 17 |
| 2015 | 2 | 10 | 12 |
| 2016 | 3 | 4 | 7 |
| 2017 | 4 | 7 | 11 |
| 2018 | 3 | 4 | 7 |
| 2019 | 4 | 7 | 11 |
| 2020 | 1 | 11 | 12 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 5 | 5 |
| 2024 | 2 | 5 | 7 |
| 2025 | 1 | 6 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholesterol, HDL" by people in Profiles.
-
Lipid profile and the variables associated with control of selected lipid parameters in patients of a large multi-specialist hospital in Poland - the Jurasz Lipid Study (JLS). Lipids Health Dis. 2025 Sep 29; 24(1):300.
-
Visit-to-visit lipid variability, coronary artery calcification, inflammation, and mortality in the Multi-Ethnic Study of Atherosclerosis. Eur J Prev Cardiol. 2025 Sep 22; 32(13):1235-1244.
-
Trends in blood-based metabolic and cardiovascular risk profiles in men during treatment for testosterone deficiency: a longitudinal, retrospective cohort study. J Sex Med. 2025 Sep 04; 22(9):1564-1571.
-
Impact of Obicetrapib on Major Adverse Cardiovascular Events in High-Risk Patients: A Pooled Analysis. J Am Coll Cardiol. 2025 Oct 07; 86(14):1046-1056.
-
Laparoscopically confirmed endometriosis and midlife plasma markers of inflammation, cholesterol, and adipokines among participants in the Nurses' Health Study II. Maturitas. 2025 Sep; 200:108663.
-
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk. N Engl J Med. 2025 Jul 03; 393(1):51-61.
-
Refinement of a Published Gene-Physical Activity Interaction Impacting HDL-Cholesterol: Role of Sex and Lipoprotein Subfractions. Genet Epidemiol. 2025 Jan; 49(1):e22607.
-
Characterising the lipid profile of paediatric patients with anomalous aortic origins of a coronary artery. Cardiol Young. 2025 Feb; 35(2):311-316.
-
Prognostic value of the monocyte-to-high-density lipoprotein-cholesterol ratio in acute coronary syndrome patients: A systematic review and meta-analysis. Kardiol Pol. 2025; 83(1):52-61.
-
Individual Variation in the Distribution of Apolipoprotein B Levels Across the Spectrum of LDL-C or Non-HDL-C Levels. JAMA Cardiol. 2024 Aug 01; 9(8):741-747.